SCHAFER CULLEN CAPITAL MANAGEMENT INC - Roche Holding AG ownership

Roche Holding AG's ticker is and the CUSIP is H69293217. A total of 5 filers reported holding Roche Holding AG in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHAFER CULLEN CAPITAL MANAGEMENT INC ownership history of Roche Holding AG
ValueSharesWeighting
Q4 2020$670,000
-7.2%
1,921
-8.9%
0.01%
-9.1%
Q3 2020$722,000
-17.8%
2,109
-16.8%
0.01%
-21.4%
Q2 2020$878,000
-2.7%
2,534
-8.3%
0.01%
-6.7%
Q1 2020$902,000
-24.9%
2,763
-25.3%
0.02%
+7.1%
Q4 2019$1,201,000
+3.4%
3,699
-7.3%
0.01%0.0%
Q3 2019$1,161,000
-6.7%
3,989
-14.4%
0.01%
-6.7%
Q2 2019$1,244,000
-15.9%
4,659
-13.2%
0.02%
-31.8%
Q1 2019$1,480,000
-16.8%
5,370
-25.2%
0.02%
-18.5%
Q4 2018$1,778,000
-4.5%
7,182
-6.6%
0.03%
+12.5%
Q3 2018$1,862,000
+28.9%
7,687
+18.5%
0.02%
+26.3%
Q2 2018$1,445,000
-6.3%
6,487
-3.6%
0.02%0.0%
Q1 2018$1,542,000
-14.4%
6,728
-5.6%
0.02%
-9.5%
Q4 2017$1,801,000
-2.5%
7,124
-1.5%
0.02%
-4.5%
Q3 2017$1,847,000
-2.5%
7,234
-2.7%
0.02%
-8.3%
Q2 2017$1,894,000
+29.6%
7,436
+30.0%
0.02%
+26.3%
Q1 2017$1,461,000
+10.0%
5,722
-1.5%
0.02%
+5.6%
Q4 2016$1,328,000
-8.8%
5,812
-1.0%
0.02%0.0%
Q3 2016$1,456,000
-5.4%
5,8700.0%0.02%
-5.3%
Q2 2016$1,539,000
+6.0%
5,870
-0.1%
0.02%
+5.6%
Q1 2016$1,452,000
-7.4%
5,875
+3.4%
0.02%
-5.3%
Q4 2015$1,568,000
-5.3%
5,680
-9.5%
0.02%0.0%
Q3 2015$1,655,000
-7.9%
6,275
-2.1%
0.02%0.0%
Q2 2015$1,796,000
+1.1%
6,409
-0.4%
0.02%
+5.6%
Q1 2015$1,776,000
+4.3%
6,434
+2.6%
0.02%
-18.2%
Q4 2014$1,703,000
-33.4%
6,269
-27.4%
0.02%
-8.3%
Q3 2014$2,557,000
-3.6%
8,630
-3.0%
0.02%0.0%
Q2 2014$2,653,000
-3.1%
8,895
-2.6%
0.02%
-11.1%
Q1 2014$2,739,000
+2.0%
9,130
-4.7%
0.03%0.0%
Q4 2013$2,684,000
-25.8%
9,580
-28.6%
0.03%
-32.5%
Q3 2013$3,618,000
-20.3%
13,415
-26.6%
0.04%
-25.9%
Q2 2013$4,539,00018,2750.05%
Other shareholders
Roche Holding AG shareholders Q1 2021
NameSharesValueWeighting ↓
Boston Common Asset Management, LLC 84,168$23,0430.55%
KENNEDY CAPITAL MANAGEMENT LLC 12,352$3,382,1870.08%
View complete list of Roche Holding AG shareholders